🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To explore the efficacy and safety of TQB2825 injection combined immunochem...
Status
Recruiting
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2025-04-23
Trial ID
NCT06829771
Treatments Being Tested
The primary objective of the study is to compare the complete response (CR)...
Status
Completed
Location
Teva Investigational Site 165
Start Date
2009-04-30
Trial ID
NCT00877006
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of doxorubi...
Status
Terminated
Location
Groupe d'Etude des Lymphomes de l'adulte
Start Date
2001-10-16
Trial ID
NCT00135499
To establish standard therapy for patients with advanced-stage low grade B-...
Status
Completed
Location
Aichi Medical University
Start Date
2002-09
Trial ID
NCT00147121
Treatments Being Tested
To assess the efficacy and safety of camrelizumab combined with rituximab, ...
Status
Unknown
Location
Multiple Locations
Start Date
2022-06-01
Trial ID
NCT05093140
Treatments Being Tested
The purpose of this study is to evaluate: 1. whether an imaging test calle...
Status
Completed
Location
Tom Baker Cancer Centre
Start Date
2007-07
Trial ID
NCT00530179
Treatments Being Tested
The purpose of this multi-center, single arm, phase Ⅱ clinical trail is to ...
Status
Unknown
Location
Multiple Locations
Start Date
2024-06-01
Trial ID
NCT06412068
Treatments Being Tested
This open-label, randomized, phase Ib study will assess the safety and effi...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00825149
Treatments Being Tested
The purpose of this study is to measure the efficacy and safety of R-mini-C...
Status
Recruiting
Location
Research Site
Start Date
2025-11-11
Trial ID
NCT07215585
Treatments Being Tested
Non-Hodgkin lymphoma (NHL), with high aggressiveness and mortality, is one ...
Status
Unknown
Location
Department of Hematology, Shandong Provincial Hospital
Start Date
2021-03-01
Trial ID
NCT05164770